Ann Hynes
Stock Analyst at Mizuho
(4.39)
# 375
Out of 4,996 analysts
253
Total ratings
64.36%
Success rate
12.67%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $32 → $22 | $24.53 | -10.31% | 12 | Aug 14, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $350 → $300 | $344.08 | -12.81% | 20 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $328 → $510 | $496.79 | +2.66% | 3 | Jul 25, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $190 → $225 | $179.56 | +25.31% | 13 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $173 → $225 | $163.79 | +37.37% | 16 | Jul 25, 2025 | |
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $202.00 | -3.96% | 15 | Jul 11, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $400 → $330 | $191.98 | +71.89% | 9 | Jul 11, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $8 → $7 | $8.68 | -19.35% | 4 | Jul 11, 2025 | |
| CNC Centene | Maintains: Neutral | $71 → $40 | $34.86 | +14.74% | 8 | Jul 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $188.99 | +0.01% | 15 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $305 → $316 | $254.95 | +23.95% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $455 → $505 | $318.61 | +58.50% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $148.56 | +4.33% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $75.77 | +0.30% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $13.26 | +35.75% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $16.30 | -7.98% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $153.71 | -21.93% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $27.39 | -26.98% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $20.82 | +34.49% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $126.70 | -25.02% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $286.17 | +34.54% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $200.85 | -0.42% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $2.63 | +10,090.11% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $760.55 | -33.60% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $280.61 | -18.04% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $419.08 | -34.38% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $21.84 | +128.94% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.46 | +3,804.11% | 1 | Sep 21, 2017 |
Acadia Healthcare Company
Aug 14, 2025
Maintains: Neutral
Price Target: $32 → $22
Current: $24.53
Upside: -10.31%
UnitedHealth Group
Aug 7, 2025
Maintains: Outperform
Price Target: $350 → $300
Current: $344.08
Upside: -12.81%
Medpace Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $328 → $510
Current: $496.79
Upside: +2.66%
IQVIA Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $179.56
Upside: +25.31%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $163.79
Upside: +37.37%
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $202.00
Upside: -3.96%
Molina Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $191.98
Upside: +71.89%
Fortrea Holdings
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $8.68
Upside: -19.35%
Centene
Jul 11, 2025
Maintains: Neutral
Price Target: $71 → $40
Current: $34.86
Upside: +14.74%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $188.99
Upside: +0.01%
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $254.95
Upside: +23.95%
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $318.61
Upside: +58.50%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $148.56
Upside: +4.33%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $75.77
Upside: +0.30%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $13.26
Upside: +35.75%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $16.30
Upside: -7.98%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $153.71
Upside: -21.93%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $27.39
Upside: -26.98%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $20.82
Upside: +34.49%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $126.70
Upside: -25.02%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $286.17
Upside: +34.54%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $200.85
Upside: -0.42%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $2.63
Upside: +10,090.11%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $760.55
Upside: -33.60%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $280.61
Upside: -18.04%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $419.08
Upside: -34.38%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $21.84
Upside: +128.94%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.46
Upside: +3,804.11%